false
0000727346
0000727346
2026-03-12
2026-03-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 12, 2026
SELECTIS
HEALTH, INC.
(Exact
Name of Registrant as Specified in its Charter)
| Utah
|
|
0-15415
|
|
87-0340206
|
(State
or other jurisdiction
of
incorporation) |
|
Commission
File
Number |
|
(I.R.S.
Employer
Identification
number) |
600
17th St.,
Ste 2800 South,
Denver,
CO 80202
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (720) 680-0808
(Former
name or former address, if changed since last report)
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each Class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
| N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| ITEM
5.02 |
APPOINTMENT
OF DIRECTORS |
Effective
March 12, 2026, the Board of Directors of Selectis Health, Inc, a Utah corporation (the “Company”) approved the appointment
of Mr. Richard Huebner to serve as a member of the Board of Directors of Company.
The
following is biographical information on the new Board member:
Richard
Huebner, age 68 has served as the senior managing partner and investment banker of GVC Capital LLC since 2001 to the present. Prior to
this Mr. Huebner was a registered investment advisor from 2000 to 2001. He was also an Executive Vice President at Fiserv Correspondent
Services from 1984 to 2000. Mr. Huebner served in various roles including General Counsel, Director, Executive Committee Member, Compliance
Officer, Equities Desk Trader, Vice President, Senior and Executive Vice Present at Hanifen Imhoff Inc, (1979) Hanifen Imhoff Holding
Company, Hanifen Imhoff Investments, Hanifen Imhoff Clearing Corp from 1984 through 1997. From 1980 through 1983 he held the positions
of Law Clerk, Compliance Officer and Assistant General Counsel and First Mid America, Inc.
Mr.
Huebner received a Bachelor’s degree from Hastings College in Nebraska (1979) and a Juris Doctorate degree from University of Nebraska
(1982).
Mr.
Huebner will be eligible to participate in the Company’s previously approved Outside Directors Compensation Plan under which he
will receive an annual stipend of $30,000, payable quarterly in cash.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
| |
Selectis
Health, Inc. |
| |
(Registrant) |
| |
|
| Dated:
March 18, 2026 |
/s/
Adam Desmond |
| |
Adam
Desmond CEO |
